Columbia Care and Rhinomed Agree to Develop Nasal Delivery Cannabis Product
Columbia Care, LLC announced on June 21st the company’s entrance into a license agreement with Rhinomed (ASX: RNO) to develop a cannabis product line where the products will be delivered through nasal passageways.
Rhinomed is an Australian-based company that specifically works with nasal respiratory products. However, Columbia Care will keep the exclusive rights to develop, import, market, promote, distribute, and sell the product, which the two companies will collaborate in creating, in the United States.
According to the terms of the agreement the two companies will collaborate on the development of one or multiple versions of a nasal cannabis product. This product will be developed in Columbia Care’s facilities and will utilize Columbia Care’s pharmaceutical-grade cannabis medicines.
Columbia Care and Rhinomed Agree to Develop Nasal Delivery Cannabis Product
About Cannin: Your Cannabis Stocks Resource
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In
